• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Johnson & Johnson (NY:JNJ)

    238.64 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EST, Feb 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,562
    Open 238.64
    Bid (Size) 237.84 (100)
    Ask (Size) 239.98 (300)
    Prev. Close 238.64
    Today's Range 238.64 - 238.64
    52wk Range 141.50 - 240.94
    Shares Outstanding 2,628,679,824
    Dividend Yield 2.18%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    News headline image
    5 Stocks and ETFs to Help Shield Your Portfolio During Volatility ↗
    Via MarketBeat
    Topics ETFs

    Performance

    YTD
    +15.1%
    +15.1%
    1 Month
    +13.8%
    +13.8%
    3 Month
    +26.7%
    +26.7%
    6 Month
    +37.3%
    +37.3%
    1 Year
    +54.7%
    +54.7%

    More News

    Read More
    News headline image
    Johnson & Johnson Reports 90% AFib Freedom In Early Heart Device Study ↗
    Via Benzinga
    News headline image
    What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill. ↗
    Via The Motley Fool
    Topics Bonds
    Johnson & Johnson (NYSE:JNJ) Stands Out as a High-Quality Dividend Aristocrat for Income Investors ↗
    Via Chartmill
    Johnson & Johnson's Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy? ↗
    Via The Motley Fool
    News headline image
    Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
    From Johnson & Johnson
    Via Business Wire
    News headline image
    Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut ↗
    Via MarketBeat
    News headline image
    Johnson & Johnson Is A Resilient Blue-Chip Stock And It Just Hit New All-Time Highs ↗
    Via Talk Markets
    News headline image
    Johnson & Johnson Is a Resilient Blue-Chip Stock and It Just Hit New All-Time Highs
    Via Barchart.com
    News headline image
    The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
    Via Finterra
    Topics ETFs Economy Initial Public Offering
    News headline image
    The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
    Via MarketMinute
    Topics Supply Chain
    News headline image
    Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)
    Via Finterra
    Topics Product Recall World Trade
    News headline image
    The Pharma Reckoning: 2026 Earnings Unveil a New Era of 'TrumpRx' Deals and Looming Patent Cliffs
    Via MarketMinute
    Topics Economy Government Intellectual Property
    News headline image
    Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference
    From Johnson & Johnson
    Via Business Wire
    News headline image
    The Biological Singularity: How AlphaFold 3 Is Rewriting the Blueprint of Drug Discovery
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    Where Will AbbVie Be in 5 Years? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    All It Takes Is $13,000 Invested in Each of These 2 Dividend Kings to Help Generate $1,000 in Passive Income in 2026 ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    3 Vanguard ETFs to Buy to Protect Your Portfolio from a Potential Stock Market Crash ↗
    Via The Motley Fool
    Topics Bonds ETFs Regulatory Compliance
    News headline image
    Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist ↗
    Via The Motley Fool
    News headline image
    1 Super-Safe High-Yield Dividend King Stock to Buy Even if There's a Stock Market Sell-Off in 2026 ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy World Trade
    News headline image
    This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Economic Alarm Bells: LEI Index Slips 0.3% as US Economy Navigates a Fragile 2026 Start
    Via MarketMinute
    Topics Artificial Intelligence Economy World Trade
    News headline image
    What Are Wall Street Analysts' Target Price for Johnson & Johnson Stock?
    Via Barchart.com
    Topics ETFs World Trade

    Frequently Asked Questions

    Is Johnson & Johnson publicly traded?
    Yes, Johnson & Johnson is publicly traded.
    What exchange does Johnson & Johnson trade on?
    Johnson & Johnson trades on the New York Stock Exchange
    What is the ticker symbol for Johnson & Johnson?
    The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
    What is the current price of Johnson & Johnson?
    The current price of Johnson & Johnson is 238.64
    When was Johnson & Johnson last traded?
    The last trade of Johnson & Johnson was at 02/09/26 07:00 PM ET
    What is the market capitalization of Johnson & Johnson?
    The market capitalization of Johnson & Johnson is 627.31B
    How many shares of Johnson & Johnson are outstanding?
    Johnson & Johnson has 627B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.